Trial Profile
Safety and efficacy of pertuzumab plus trastuzumab and taxanes in patients with HER2+ metastatic breast cancer:A multicenter, retrospective-prospective, observational study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Oct 2020
Price :
$35
*
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab (Primary) ; Docetaxel; Paclitaxel; Vinorelbine
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Acronyms G.O.N.O. SUPER
- 21 Sep 2020 Final results presented at the 45th European Society for Medical Oncology Congress.
- 05 Jun 2018 Preliminary results (As of Jan 31st 2018; n=300) presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 12 Jan 2018 New trial record